Putnam, an Inizio Advisory Company, is a premier strategic consulting partner for pharmaceutical and life science companies serving a range of biopharmaceutical, diagnostics, medtech, and private equity/venture capital clients. For more than 30 years, we have provided high-impact strategic advice and analytical services, helping our clients solve their most complex challenges across the patient journey and franchise lifecycle to bring preventions and treatments to those that need them. We offer an unparalleled depth and breadth of advisory service expertise combined with scientific and technical capabilities across strategic and therapeutic areas. We listen to client needs, help shape hypotheses, analyze data, and advise on the strategy of life-changing therapies, empowering better decisions to create long-term value for patients. Our Putnam PHMR team is part of our Value, Pricing and Access (VPA) practice area function, where our team members bring a breadth of knowledge across scientific and technical capabilities. We are a team of highly qualified HTA experts, health economists, and research scientists, helping clients to demonstrate and communicate value essential for pricing and market access success. We are proudly part of Inizio Advisory, a trusted advisor for pharmaceutical and life science companies offering sector specific connected solutions.